William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
Audax Private Equity Exits EIS
-
Kura Sushi (KRUS) Prices 696K Share Offering at $85/sh
-
Nusano to Present at William Blair Virtual Radiopharmaceuticals Event
-
Kura Sushi USA Announces Pricing of Public Offering of Common Stock
-
Kura Sushi (KRUS) Launches Share Offering
-
Kura Sushi USA Announces Launch of Public Offering of Common Stock
-
Chipotle veteran Scott Boatwright named permanent CEO
-
Morgan Stanley's PE arm to sell HVAC firm to Goldman Sachs Alternatives
-
Morgan Stanley (MS) Capital Partners Agrees to Sell Sila Services
-
Morgan Stanley Capital Partners Agrees to Sell Sila Services
-
Sila Services Announces Equity Investment From Goldman Sachs Alternatives’ Private Equity Business
-
ITM to Participate in Upcoming Investor Conferences
-
ITM to Participate in Upcoming Investor Conferences
-
Form 13F-HR WILLIAM BLAIR INVESTMENT For: Sep 30
-
William Blair Downgrades agilon health Inc (AGL) to Market Perform
-
LifeMD Reports Third Quarter 2024 Results
-
Avid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction
-
William Blair Expands Equity Capital Markets Team, Adding Ilya Blanter in New York as Head of Equity-Linked Capital Markets
-
The Beekman Group Announces the Sale of Riccobene Family Dentistry, a Leading Dental Service Organization in the Southeast Region
-
William Blair Starts CAMP4 Therapeutics Corp (CAMP) at Outperform
-
William Blair Reiterates Underperform Rating on Palantir Technologies Inc. (PLTR)
-
Comvest Private Equity Announces Investment in Riccobene Associates Family Dentistry
-
Neurogene (NGNE) Announces Oversubscribed $200 Million Private Placement
-
Neurogene Announces Oversubscribed $200 Million Private Placement
-
Union Capital Completes Sale of Chef Robert Irvine's FITCRUNCH and Bakery Barn to 1440 Foods
-
1440 Foods Acquires FITCRUNCH to Enhance Leading Portfolio of Active Nutrition Brands
-
QSR Automations Announces Majority Growth Investment from Battery Ventures
-
William Blair Upgrades argenx SE (ARGX) to Outperform
-
Serent Capital Announces Acquisition of KORE by Two Circles
-
William Blair Downgrades Altair Engineering (ALTR) to Market Perform
-
Global Payments sharpens core focus with $1.1 billion medical software unit sale
-
William Blair Downgrades BioMarin Pharmaceutical Inc. (BMRN) to Market Perform
-
SFEP-Backed SV Labs Announces Acquisition of Sigan Industries
-
PayPal's revenue forecast fails to impress as profit push puts growth behind
-
Royal Caribbean raises annual profit forecast on strong cruise demand, price hikes
-
Woolpert Strengthens M&A Team, Welcomes Director of Mergers and Acquisitions Aaron Scro
-
William Blair Starts Primo Water Corporation (PRMW) at Outperform
-
Ingram Micro (INGM) Prices 18.6M Share IPO at $22/sh
-
Ingram Micro Announces Pricing of Its Initial Public Offering
-
Starbucks baristas have one message for new CEO: change!
-
Starbucks suspends annual forecast as new CEO prepares turnaround plan
-
CardFlight Receives Growth Investment from WestView Capital Partners
-
Royal Caribbean Cruises (RCL) Mentioned Positive at William Blair
-
AmEx profit beats as expense discipline offsets spending slowdown
-
William Blair Upgrades Baldwin Insurance (BWIN) to Outperform
-
William Blair Bolsters Cybersecurity Investment Banking With Senior Hire
-
VSE Corp. (VSEC) Prices 1.72M Share Offering at $87/sh
-
VSE Corporation Prices Public Offering of Common Stock
-
CeriBell, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
-
Upstream Bio Announces Closing of $293 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

